| Name | Title | Contact Details |
|---|---|---|
Roger Colon |
Director of Cybersecurity | Profile |
Meet AdCellerant, the leader in local digital AdCellerant is a technology and digital advertising company focused on making quality digital marketing accessible to every business. AdCellerant achieves this goal by partnering with local marketers, media...
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
CommentSold helps businesses sell products digitally. With our platform, businesses can manage inventory, automate invoicing, enable sales through social networking, and power web and mobile applications. Our mission is to democratize e-commerce by creating affordable, innovative, and easy-to-use software solutions.
Grolen Communications is a Manchester, NH-based company in the Software and Internet sector.